While lifetime risk of developing ovarian cancer for women in the general population is about 1.2% [3], the risk was estimated to be 39–59% and 11–17% for women who carry BRCA1 and BRCA2 mutations, respectively, by age 70–80 [4,5,6,7]. The gene discussed is BRCA2; the disease is ovarian carcinoma.